GNBT
Generex Biotechnology Reports Preliminary Outcomes and Trends From Ongoing Phase III Clinical Trial of Generex Oral-lyn(TM)
Findings Based on In-Process Data for Subjects That Completed the 6-Month Treatment Phase of the Study Demonstrate Several Favorable Comparisons to Injectable Insulin :roll:
ganz schlau werd ich nicht aus dem Bericht